Snapshots

Search

Search managers or tickers

RXRX Recursion Pharmaceuticals In

held by 1 manager in Q1 2023 Latest
Manager% of their portfolioHeldActivityValueShares
Stanley Druckenmiller Duquesne Family Office 0.40% 1.8 yr $9M 1,385,950